Successful treatment with repeated dexamethasone implant injections for recurrent macular edema after acute retinal necrosis
Tóm tắt
The treatment of recurrent cystoid macular edema associated with acute retinal necrosis is challenging due to the concern that treatment with intravitreal steroids may reactivate the retinitis. An immunocompetent patient diagnosed with acute retinal necrosis was treated with oral valacyclovir and intravitreal injections of foscarnet. Giant tears in her retina necessitated a vitrectomy with silicone oil. She developed cystoid macular edema after the removal of the silicone oil. The edema responded to high-dose prednisolone but recurred when the dose was tapered to 20 mg daily. Under close surveillance and increased antiviral medication, she was treated with a dexamethasone implant with complete resolution of the edema. Unfortunately, the edema recurred, and the treatment had to be repeated. Over 18 months, she received five dexamethasone implants without recurrence of the viral retinitis. This case shows successful treatment of recurring cystoid macular edema following acute retinal necrosis with repeated intravitreal dexamethasone implants in a patient receiving valacyclovir maintenance treatment.
Tài liệu tham khảo
Koronis S, Stavrakas P, Balidis M, Kozeis N, Tranos PG (2019) Update in treatment of uveitic macular edema. Drug Des Devel Ther 13:667–680. https://doi.org/10.2147/DDDT.S166092
Lardenoye CW, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113(8):1446–1449. https://doi.org/10.1016/j.ophtha.2006.03.027
Mackensen F, Heinz C, Becker MD, Heiligenhaus A (2008) Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Retina 28(1):41–45. https://doi.org/10.1097/IAE.0b013e318156db75
Majumder PD, Biswas J, Ambreen A, Amin R, Pannu ZR, Bedda AM (2016) Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis. J Ophthalmic Inflamm Infect 6(1):49. https://doi.org/10.1186/s12348-016-0116-x
Ortega-Evangelio L, Navarrete-Sanchis J, Williams BK, Tomas-Torrent JM (2018) Aflibercept in the management of acute retinal necrosis syndrome-related macular edema. Eur J Ophthalmol 28(2):259–261. https://doi.org/10.5301/ejo.5001039
Powell B, Wang D, Llop S, Rosen RB (2020) Management strategies of acute retinal necrosis: current perspectives. Clin Ophthalmol 14:1931–1943. https://doi.org/10.2147/OPTH.S258488
Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80(4):332–336. https://doi.org/10.1136/bjo.80.4.332
Satoh N, Abe T, Nakajima A, Sakuragi S (1998) Recurrent varicella-zoster virus retinitis in a patient treated with systemic corticosteroids. Ocul Immunol Inflamm 6(3):185–188. https://doi.org/10.1076/ocii.6.3.185.4040
Tam PM, Hooper CY, Lightman S (2010) Antiviral selection in the management of acute retinal necrosis. Clin Ophthalmol 4:11–20
Weissman HM, Biousse V, Schechter MC, Del Rio C, Yeh S (2015) Bilateral central retinal artery occlusion associated with herpes simplex virus-associated acute retinal necrosis and meningitis: case report and literature review. Ophthalmic Surg Lasers Imaging Retina 46(2):279–283. https://doi.org/10.3928/23258160-20150213-24
Wong RW, Jumper JM, McDonald HR, Johnson RN, Fu A, Lujan BJ, Cunningham ET Jr (2013) Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol 97(5):545–552. https://doi.org/10.1136/bjophthalmol-2012-301983